BMG LABTECH Announces the new Omega Family of Multifunction Microplate Readers
Product News Jun 18, 2007
BMG LABTECH announces the new Omega family of multifunction microplate readers with high resolution, full UV/Vis spectrometer based absorbance. This new family of readers combines all of the speed, sensitivity and flexibility needed for life science applications and research.
The Omega line is made up of four models: the SPECTROstar Omega, a spectrophotometer; the LUMIstar Omega, a luminometer; the FLUOstar Omega, a multidetection reader (fluorescence, time-resolved fluorescence, luminescence, and absorbance); and the POLARstar Omega, a multidetection reader with additional simultaneous dual emission and fluorescence polarization mode.
Due to the absolute modular concept of the Omega family of readers, the SPECTROstar Omega and the LUMIstar Omega are upgradeable to a multidetection microplate reader whenever the need for fluorescence based experiments arrives.
According to Company, the Omega readers can read 384-well plate in less than 15 seconds. In addition, the series offers a number of features: integrated injectors with direct access to the measurement position; photometric spectral scans; top and bottom reading; well scanning; temperature control up to 60°C; shaking; stacker and robot compatibility; and a gas vent connection to support all major types of cell based assays.
Main technical innovations of the reader series include extensive upgradeability, as well as the capability of capturing a full absorbance spectrum (220 – 850 nm) in one second per well, at a resolution of 1 nm. Furthermore, a UV-enhanced flashlamp and high speed plate shaking are also available.
The Omega series of microplate readers will be delivered with a software package, including proprietary evaluation software. This evaluation software displays and analyzes endpoint, kinetic and spectral data through data reduction algorithms and various curve fitting options. It is compatible with the new Windows Vista™ operating system and is fully compliant with FDA regulation 21 CFR Part 11.